Vir Bio appoints CEO Marianne De Backer to additional role of President

Vir Biotechnology, Inc.

On March 4, 2026, Vir Bio's Board appointed CEO Marianne De Backer to the additional position of President.
No arrangements or understandings exist between Dr. De Backer and any person regarding her appointment as President.
No family relationship between Dr. De Backer and any Vir Bio director or executive officer.
Dr. De Backer has no direct or indirect interest in any transaction requiring Item 404(a) disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.